Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Kimberly Holst Added: 2 weeks ago
Navigate the strategic complexities of transcatheter mitral valve replacement in multivalvular disease with Dr Kimberly HolstThis presentation, part of Women As One's comprehensive Structural Interventions track, provides a systematic framework for approaching multivalvular heart disease. The presentation establishes the foundational principle of strategic intervention sequencing in high-risk… View more
Job title: Professor of Cardiology and Senior Physician
Job title: Physician
Author(s): Harriette Van Spall , Michael Andrew Borger Added: 2 months ago
ESC Congress 2025 - Dr Harriette Van Spall (McMaster University, Canada) sits down with Professor Michael Borger (University of Leipzig Heart Center, Germany), Co-Chair of the newly released 2025 ESC/EACTS Guidelines for the Management of Valvular Heart Disease.The new guidelines bring together the latest evidence and expert consensus on how to diagnose, evaluate, and treat patients with valvular… View more
Author(s): Michelle Kittleson Added: 2 months ago
ESC Congress 2025 - In this video, Dr Michelle Kittleson (Cedars-Sinai Heart Institute, US) outlines the hot-line data from the congress that are expected to have an impact on clinical practice in the heart failure space.Trials covered in detail include:REBOOT-CNIC: Beta-Blockers after Myocardial Infarction without Reduced Ejection FractionBETAMI-DANBLOCK: Beta-Blockers after Myocardial… View more
Job title: Professor of Cardiology and Senior Physician
Author(s): Renate B Schnabel , Eva Gerdts , Added: 2 months ago
Cardiovascular disease in women is frequently underdiagnosed, with heart failure often overlooked due to subtle symptoms and persistent clinical bias. In this on-demand symposium, leading experts explore why cardiovascular disease is missed in women, the unique risks and presentations of female heart failure and how early detection of atrial fibrillation can improve outcomes. Chaired by Prof… View more
Author(s): Harriette Van Spall , Faiez Zannad Added: 2 months ago
ESC Congress 2025 - Vericiguat did not reduce the risk of cardiovascular mortality and hospitalization in heart failure with reduced ejection fraction, fewer cardiovascular deaths and all-cause deaths were observed.Host, Dr Harriette Van Spall (McMaster University, CA) is joined on-site at ESC Congress 2025 in Madrid by Dr Faiez Zannad (University of Lorraine, FR) to discuss pivotal results from… View more
Author(s): Ruth Masterson Creber Added: 7 months ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different… View more